Stefan Endres

36.6k citations

276 papers · 28.6k indexed · 15 hit papers · h-index 83

Impact in

Immunology top 0.02%
- Immune Response and Inflammation
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- interferon and immune responses
- T-cell and B-cell Immunology
Oncology top 0.2%

Papers in

Immunology 181
- Immune Response and Inflammation 86
- Immunotherapy and Immune Responses 83
- Immune Cell Function and Interaction 63
- T-cell and B-cell Immunology 27
- interferon and immune responses 23
Oncology 67
- CAR-T cell therapy research 38
- Cancer Immunotherapy and Biomarkers 22

Co-authors: Gunther Hartmann Veit Hornung Simon Rothenfußer Andreas Eigler Sebastian Kobold Thomas Giese Anne Krug Hendrik Poeck
Journals: The Journal of Immunology (32 papers)European Journal of Immunology (10 papers)Journal of Leukocyte Biology (8 papers)Blood (7 papers)Cytokine (5 papers)
Partner nations: Germany United States Switzerland

In The Last Decade

Stefan Endres

270 papers receiving 27.8k citations

Hit Papers

15 papers align trajectories log scale

Interleukins in cancer: from biology to therapy 2021 · 528 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2021 Nature reviews. Cancer
2019 Journal of Experimental & Clinical Cancer Research
2019 International Journal of Molecular Sciences
2018 British Journal of Cancer
2010 Gut
2009 Nature
2006 Science
2005 Nature Medicine
2002 The Journal of Immunology
2001 European Journal of Immunology
2001 European Journal of Immunology
1991 Journal of Nutrition
1990 The Journal of Infectious Diseases
1990 Blood
1989 New England Journal of Medicine

Peers

Countries citing papers authored by Stefan Endres

Since Specialization

Citations

This map shows the geographic impact of Stefan Endres's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Endres with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Endres more than expected).

Fields of papers citing papers by Stefan Endres

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefan Endres. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Endres. The network helps show where Stefan Endres may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Stefan Endres, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Stefan Endres Line = papers co-authored together Stefan Endres links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Comparative performance of scFv-based anti-BCMA CAR formats for improved T cell therapy in multiple myeloma Cancer Immunology Immunotherapy ·Sophia Stock, Marcos Amato, Adrian Gottschlich, Janina Dörr, Florian Märkl, E. Gosset, Chinelo Patience Ohanyere, Ruth Grünmeier, Kai Rejeski, David M. Cordas dos Santos, Sebastian Theurich, Michael von Bergwelt‐Baildon, Stefan Endres, Marion Subklewe, Sebastian Kobold	2024	2
2	Association between bisphosphonate use and COVID-19 related outcomes eLife ·Jeffrey Thompson, 誠市坪, Tobias Dreischulte, Olga Barreiro, Rodrigo J. Gonzalez, Pavel Hanč, H Mamok, Harold R. Neely, Marietta Rottenkolber, Thomas L. Haskell, Stefan Endres, Ulrich H. von Andrian	2023	4
3	Rational design of PD-1-CD28 immunostimulatory fusion proteins for CAR T cell therapy British Journal of Cancer ·Mauricio Navarreta, Bruno L. Cadilha, Okan Bolukbasib, Mohamed-Reda Benmebarek, Florian Märkl, Ana Catarina Bispo Subtil, Eläinlääketieteellinen tiedekunta, Daria Briukhovetska, Unna Inger Lassiter, W. R. Smith, Pia Winter, E. Gosset, Ruth Grünmeier, Matthias Seifert, A. Vallier, Tobias Feuchtinger, Stefan Endres, Sebastian Kobold	2023	10
4	Chimeric antigen receptor T cells engineered to recognize the P329G-mutated Fc part of effector-silenced tumor antigen-targeting human IgG1 antibodies enable modular targeting of solid tumors Journal for ImmunoTherapy of Cancer ·Sophia Stock, Mohamed-Reda Benmebarek, А.А. Сивков, A. Mehdi, Christian Jöst, Kay‐Gunnar Stubenrauch, J. Benz, Anne Freimoser–Grundschober, Ekkehard Moessner, Pablo Umaña, Marion Subklewe, Stefan Endres, Christian Klein, Sebastian Kobold	2022	19
5	OAS1/RNase L executes RIG-I ligand–dependent tumor cell apoptosis Science Immunology ·Ling-long GUO, Ellie C Adam, Carina C. de Oliveira Mann, Stephan A. Müller, Michael Kluge, Philipp Metzger, Meino Rohlfs, Partice Rondonuwu, Xin XUN, Stefan F. Lichtenthaler, Karl‐Peter Hopfner, Stefan Endres, Simon Rothenfußer, Caroline C. Friedel, Peter Duewell, Max Schnurr, Lars M. Koenig	2021	29
6	Systemic but not MDSC-specific IRF4 deficiency promotes an immunosuppressed tumor microenvironment in a murine pancreatic cancer model Cancer Immunology Immunotherapy ·Philipp Metzger, Sabrina V. Kirchleitner, Ling-long GUO, Partice Rondonuwu, 多喜博文, Steffen Ormanns, Matthias Gunzer, Maciej Lech, Kirsten Lauber, Stefan Endres, Peter Duewell, Max Schnurr, Lars M. König	2020	14
7	Utility of the RIG-I Agonist Triphosphate RNA for Melanoma Therapy Molecular Cancer Therapeutics ·Mike W. Helms, Kerstin Jahn‐Hofmann, Felix Gnerlich, W. Emboden, Monika Braun, Christopher W. Grote, Adolphe Aganze, Kaj Grandien, Joachim Theilhaber, Hui Cao, Timothy R. Wagenaar, Max Schnurr, Stefan Endres, Dmitri Wiederschain, Sabine Scheidler, Simon Rothenfußer, Bodo Brunner, Lars M. König	2019	13
8	Limitations in the Design of Chimeric Antigen Receptors for Cancer Therapy Cells ·Stefan Stoiber, Bruno L. Cadilha, Mohamed-Reda Benmebarek, Stefanie Lesch, Stefan Endres, Sebastian Kobold	2019	140
9	Killing Mechanisms of Chimeric Antigen Receptor (CAR) T Cells International Journal of Molecular Sciences ·Mohamed-Reda Benmebarek, Clara H. Karches, Bruno L. Cadilha, Stefanie Lesch, Stefan Endres, Sebastian Kobold Hit paper breakdown →	2019	377
10	CCL1 is a major regulatory T cell attracting factor in human breast cancer BMC Cancer ·Wycliffe Lugoev, Ignazio Piseddu, Gabriela M. Wiedemann, Michael Lauseker, Christina Kühn, Simone Hofmann, Elisa Schmoeckel, Stefan Endres, Doris Mayr, Udo Jeschke, David Anz	2018	58
11	Suppression of Intratumoral CCL22 by Type I Interferon Inhibits Migration of Regulatory T Cells and Blocks Cancer Progression Cancer Research ·David Anz, Moritz Rapp, Stephan Eiber, Viktor H. Koelzer, Raffael Thaler, Sascha Haubner, Maximilian M. L. Knott, Sarah Nagel, Michaela Golić, Gabriela M. Wiedemann, Franz Bauernfeind, Cornelia Wurzenberger, Veit Hornung, Christoph Scholz, Doris Mayr, Simon Rothenfußer, Stefan Endres, Carole Bourquin	2015	63
12	DC Micro Grid Control System Based On Intelligent Power Units Publikationsdatenbank der Fraunhofer-Gesellschaft (Fraunhofer-Gesellschaft) ·Stefan Endres, Stefan Zeltner, AHMAD ALKHATATNEH	2015	1
13	Therapeutic Efficacy of Bifunctional siRNA Combining TGF-β1 Silencing with RIG-I Activation in Pancreatic Cancer Cancer Research ·G Schwachhofer, Jiwu Wei, Peter Duewell, Sabine Hoves, Mareike R. Stieg, Mohammad Mizanur Rahman, Daniel Noerenberg, Hans‐Joachim Anders, Doris Mayr, Hendrik Poeck, Gunther Hartmann, Stefan Endres, Max Schnurr	2013	123
14	CpG Blocks Immunosuppression by Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice Clinical Cancer Research ·Rafael Indra, Nitin Sharma, N. Norimatsu, Saied Salim Beni, Pan Die-lin, Nadja Sandholzer, Moritz Rapp, David Anz, Stefan Endres, Carole Bourquin	2011	199
15	Systemic Cancer Therapy with a Small Molecule Agonist of Toll-like Receptor 7 Can Be Improved by Circumventing TLR Tolerance Cancer Research ·Carole Bourquin, C. Hotz, Daniel Noerenberg, Perihannur SİPAHİ, Simon Heidegger, S.V Karthigaipriya, Bettina Storch, Nadja Sandholzer, Cornelia Wurzenberger, David Anz, Stefan Endres	2011	68
16	Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome Gut ·Christian Bauer, Peter Duewell, Christine Mayer, Hans A. Lehr, Katherine A. Fitzgerald, M Dauer, J Tschopp, Stefan Endres, Eicke Latz, Max Schnurr Hit paper breakdown →	2010	755
17	5′-triphosphate RNA requires base-paired structures to activate antiviral signaling via RIG-I Proceedings of the National Academy of Sciences ·Andreas Schmidt, Tobias Schwerd, 厚坊浩史, Johannes C. Hellmuth, Sheng Cui, Michael Wenzel, Franziska Hoffmann, Marie‐Cécile Michallet, Robert Besch, Karl‐Peter Hopfner, Stefan Endres, Simon Rothenfußer	2009	325
18	Proapoptotic signaling induced by RIG-I and MDA-5 results in type I interferon–independent apoptosis in human melanoma cells Journal of Clinical Investigation ·Robert Besch, Hendrik Poeck, Tobias Hohenauer, Daniela Senft, Georg Häcker, Carola Berking, Veit Hornung, Stefan Endres, Thomas Ruzicka, Simon Rothenfußer, Gunther Hartmann	2009	350
19	Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines. PubMed ·Max Schnurr, Péter Galambos, Christoph Scholz, Sebastien Verdiere, M Dauer, Stefan Endres, Andreas Eigler	2001	154
20	The effect of n-3 polyunsaturated fatty acids on cardiac ventricular arrhythmias - a pilot study. Jens Hesselbjerg Christensen, Peter Gustenhoff, Ejler Ejlersen, Torben E. Jessen, Klaus Rasmussen, J. Dyerberg, Erik Berg Schmidt, Raffaele De Caterina, Stefan Endres, Steen Dalby Kristensen	1993	1

About Stefan Endres

Stefan Endres is a scholar working on Immunology, Oncology, Physiology, Nutrition and Dietetics and Biochemistry, having authored 276 papers that have together received 28.6k indexed citations. Recurring topics across this work include Immune Response and Inflammation (86 papers), Immunotherapy and Immune Responses (83 papers), Immune Cell Function and Interaction (63 papers), CAR-T cell therapy research (38 papers), T-cell and B-cell Immunology (27 papers), interferon and immune responses (23 papers), Cancer Immunotherapy and Biomarkers (22 papers) and RNA Interference and Gene Delivery (19 papers). The work is most often cited by research in Immunology (16.6k citations), Oncology (5.0k citations), Nutrition and Dietetics (2.4k citations), Molecular Biology (9.0k citations) and Microbiology (746 citations). Stefan Endres has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Gunther Hartmann, Veit Hornung, Simon Rothenfußer, Andreas Eigler, Sebastian Kobold, Thomas Giese, Anne Krug, Hendrik Poeck, Charles A. Dinarello and Max Schnurr. Their work appears in journals such as The Journal of Immunology, European Journal of Immunology, Journal of Leukocyte Biology, Blood and Cytokine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact